Determination of Type I Receptor Specificity by the Type II Receptors for TGF-β or Activin

5 November 1993

journal article
Published by American Association for the Advancement of Science (AAAS) in Science

Vol. 262 (5135) , 900-902
https://doi.org/10.1126/science.8235612

Abstract

Transforming growth factor-beta (TGF-beta) and activin signal primarily through interaction with type I and type II receptors, which are transmembrane serine-threonine kinases. Tsk 7L is a type I receptor for TGF-beta and requires coexpression of the type II TGF-beta receptor for ligand binding. Tsk 7L also specifically bound activin, when coexpressed with the type IIA activin receptor. Tsk 7L could associate with either type II receptor and the ligand binding specificity of Tsk 7L was conferred by the type II receptor. Tsk 7L can therefore act as type I receptor for both activin and TGF-beta, and possibly other ligands.

Keywords

This publication has 25 references indexed in Scilit:

Multiplicity generates diversity in the retinoic acid signalling pathways
Published by Elsevier ,2003
The alphas, betas, and kinases of cytokine receptor complexes
Cell, 1993
Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid- induced osteoblastic differentiation of multipotential mesenchymal cells
Molecular Endocrinology, 1993
Receptor-to-effector signaling through G proteins: Roles for βγ dimers as well as α subunits
Cell, 1992
Common subunits of cytokine receptors and the functional redundancy of cytokines
Trends in Biochemical Sciences, 1992
Integrins: Versatility, modulation, and signaling in cell adhesion
Cell, 1992
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
Cell, 1992
Regulatory crosstalk at composite response elements
Trends in Biochemical Sciences, 1991
The Transforming Growth Factor-beta Family
Annual Review of Cell Biology, 1990
High Efficiency DNA-Mediated Transformation of Primate Cells
Science, 1983